Navigation Links
Gene linked to worsening kidney disease in African-Americans
Date:11/20/2010

In African Americans with kidney disease related to hypertension (high blood pressure), a common gene variant is associated with a sharply increased risk of progressive kidney disease, according to a study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition. End Stage Renal Disease (ESRD) associated with hypertension occurs in the African American population at a rate 13.1 times greater than that of their white counterparts.

"We found that individuals with the common genotype were approximately 1.5 times more likely to have progressive kidney disease than those with other genotypes," comments Brad C. Astor, PhD (Johns Hopkins Bloomberg School of Public Health, Baltimore). The variant genefound in more than half of patients in the studycould contribute to the high rate of ESRD among African Americans.

The researchers performed genetic studies to identify variant forms of the gene MYH9 in 706 African Americans with kidney disease related to high blood pressure (hypertensive nephrosclerosis). The patients were drawn from a larger study, the African American Study of Kidney Disease and Hypertension (AASK).

"African Americans are at much higher risk of ESRD compared to white Americans, but the reasons for this discrepancy are unknown," Astor explains. "A genetic variation of the MYH9 gene, common in African Americans, was recently found to be associated with ESRD in individuals without diabetes. We examined the association between this genetic variation and progression of kidney disease in African Americans with hypertensive nephrosclerosis."

In the AASK patients, several MYH9 gene variants were related to the risk of decreased kidney function or ESRD. Participants with one MYH9 variant were likely to have other variants as well.

The same MYH9 gene variant previously linked to nondiabetic ESRD was also associated with an increased risk of progressive kidney disease in the AASK patients. The risk of death, ESRD, or a significant drop in kidney function was 50 percent higher than in those without the variant gene.

The variant MYH9 gene was very common, present in 55 percent of the AASK study participants. Its association with progressive kidney disease was independent of age, sex, or treatment for high blood pressure. The same variants are present in many African Americans without kidney disease, however.

The results add new evidence linking MYH9 variants to racial differences in kidney disease rates and outcomes. "Associations between specific genetic variations and outcomes can help us understand the pathophysiologic processes involved in progressive kidney disease and may lead to areas of research to slow or prevent progressive kidney disease," says Astor.

Meanwhile, newer studies raise questions about the significance of the MYH9 variants.* Those studies suggest that a neighboring gene, called APOL1, may actually be the causal gene for non-diabetic ESRD/CKD in African Americans. MYH9 may simply be a marker of the causal gene. Further studies are needed to dissect the contribution of APOL1 and MYH9 in CKD in African Americans and to determine the utility of the APOL1/MYH9 locus in diagnosis and patient management.

Astor points out that the AASK study, designed to test different blood pressure medications and blood pressure goals, had strict inclusion and exclusion criteria. "The results in this study may not be generalizable to other populations," he notes.


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology
Source:Eurekalert

Related medicine news :

1. UH physicists study behavior of enzyme linked to Alzheimers, cancer
2. Depression linked to HIV risk among South African young people, study shows
3. Prostate cancer treatment linked to higher rate of colon cancer, study finds
4. Use of AEDs in hospitals for cardiac arrest not linked with improved survival
5. Antibody Linked to Allergies on the Rise
6. Gene Variation Linked to Altruism
7. Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
8. Yogas ability to improve mood and lessen anxiety is linked to increased levels of a critical brain chemical
9. Common Eye Condition Linked to Elevated Eye Pressure
10. Childhood Abuse Linked to Diabetes Risk in Adult Women
11. Higher Statin Doses Linked to Fewer Heart Attacks, Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Metabolic Nutrition today ... this week’s 2016 Europa Games Get Fit and Sports Expo in Orlando, ... Europa Orlando Expo coming up April 29-30, was selected as the perfect event to ...
(Date:4/28/2016)... ... April 28, 2016 , ... Starting today, households across ... from USA Medical Prescription Assistance Program. They are customized to reflect the specific ... will include a ready-to-use, state-themed card and, in the near future, material that ...
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
(Date:4/28/2016)... ... April 28, 2016 , ... North Hollywood dentist , Dr. Hamid Reza, ... essential when it comes to dental accidents or critical dental problems. These issues can ... a tooth. Toothaches, knocked-out teeth, chipped teeth, and many other issues can lead to ...
(Date:4/28/2016)... OH (PRWEB) , ... April ... ... extending an invitation to those affected by a health insurance co-operative bankruptcy ... Hope’s proprietary process, individuals can receive over 1,500 FDA-approved prescription medications from ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... , April 28, 2016  ValGenesis, Inc., ... Management Solutions (VLMS) today announced that a ... for sufferers of chronic kidney failure has ... manage their corporate validation process. The global ... software solution to manage their validation processes ...
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
Breaking Medicine Technology: